191 related articles for article (PubMed ID: 19705367)
1. Sniffing the unique "odor print" of non-small-cell lung cancer with gold nanoparticles.
Barash O; Peled N; Hirsch FR; Haick H
Small; 2009 Nov; 5(22):2618-24. PubMed ID: 19705367
[TBL] [Abstract][Full Text] [Related]
2. Diagnosing lung cancer in exhaled breath using gold nanoparticles.
Peng G; Tisch U; Adams O; Hakim M; Shehada N; Broza YY; Billan S; Abdah-Bortnyak R; Kuten A; Haick H
Nat Nanotechnol; 2009 Oct; 4(10):669-73. PubMed ID: 19809459
[TBL] [Abstract][Full Text] [Related]
3. Breath testing as a method for detecting lung cancer.
Taivans I; Bukovskis M; Strazda G; Jurka N
Expert Rev Anticancer Ther; 2014 Feb; 14(2):121-3. PubMed ID: 24467216
[TBL] [Abstract][Full Text] [Related]
4. Exhaled Breath Analysis for Monitoring Response to Treatment in Advanced Lung Cancer.
Nardi-Agmon I; Abud-Hawa M; Liran O; Gai-Mor N; Ilouze M; Onn A; Bar J; Shlomi D; Haick H; Peled N
J Thorac Oncol; 2016 Jun; 11(6):827-37. PubMed ID: 26968885
[TBL] [Abstract][Full Text] [Related]
5. Application of an artificial neural network model for selection of potential lung cancer biomarkers.
Ligor T; Pater Ł; Buszewski B
J Breath Res; 2015 May; 9(2):027106. PubMed ID: 25944812
[TBL] [Abstract][Full Text] [Related]
6. Ligand-Capped Ultrapure Metal Nanoparticle Sensors for the Detection of Cutaneous Leishmaniasis Disease in Exhaled Breath.
Welearegay TG; Diouani MF; Österlund L; Ionescu F; Belgacem K; Smadhi H; Khaled S; Kidar A; Cindemir U; Laouini D; Ionescu R
ACS Sens; 2018 Dec; 3(12):2532-2540. PubMed ID: 30403135
[TBL] [Abstract][Full Text] [Related]
7. Determination of aldehydes in exhaled breath of patients with lung cancer by means of on-fiber-derivatisation SPME-GC/MS.
Poli D; Goldoni M; Corradi M; Acampa O; Carbognani P; Internullo E; Casalini A; Mutti A
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(27):2643-51. PubMed ID: 20149763
[TBL] [Abstract][Full Text] [Related]
8. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study.
Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI
Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121
[TBL] [Abstract][Full Text] [Related]
9. Determination of volatile organic compounds as biomarkers of lung cancer by SPME-GC-TOF/MS and chemometrics.
Rudnicka J; Kowalkowski T; Ligor T; Buszewski B
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3360-6. PubMed ID: 21982505
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive breath analysis of pulmonary nodules.
Peled N; Hakim M; Bunn PA; Miller YE; Kennedy TC; Mattei J; Mitchell JD; Hirsch FR; Haick H
J Thorac Oncol; 2012 Oct; 7(10):1528-33. PubMed ID: 22929969
[TBL] [Abstract][Full Text] [Related]
11. Monolayer-capped gold nanoparticles for disease detection from breath.
Nakhleh MK; Broza YY; Haick H
Nanomedicine (Lond); 2014 Sep; 9(13):1991-2002. PubMed ID: 25343349
[TBL] [Abstract][Full Text] [Related]
12. Comparative analyses of volatile organic compounds (VOCs) from patients, tumors and transformed cell lines for the validation of lung cancer-derived breath markers.
Filipiak W; Filipiak A; Sponring A; Schmid T; Zelger B; Ager C; Klodzinska E; Denz H; Pizzini A; Lucciarini P; Jamnig H; Troppmair J; Amann A
J Breath Res; 2014 Jun; 8(2):027111. PubMed ID: 24862102
[TBL] [Abstract][Full Text] [Related]
13. Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro.
Sponring A; Filipiak W; Mikoviny T; Ager C; Schubert J; Miekisch W; Amann A; Troppmair J
Anticancer Res; 2009 Jan; 29(1):419-26. PubMed ID: 19331181
[TBL] [Abstract][Full Text] [Related]
14. Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors.
Peng G; Hakim M; Broza YY; Billan S; Abdah-Bortnyak R; Kuten A; Tisch U; Haick H
Br J Cancer; 2010 Aug; 103(4):542-51. PubMed ID: 20648015
[TBL] [Abstract][Full Text] [Related]
15. Development of an Exhaled Breath Monitoring System with Semiconductive Gas Sensors, a Gas Condenser Unit, and Gas Chromatograph Columns.
Itoh T; Miwa T; Tsuruta A; Akamatsu T; Izu N; Shin W; Park J; Hida T; Eda T; Setoguchi Y
Sensors (Basel); 2016 Nov; 16(11):. PubMed ID: 27834896
[TBL] [Abstract][Full Text] [Related]
16. Sensor arrays based on nanoparticles for early detection of kidney injury by breath samples.
Nakhleh MK; Amal H; Awad H; Gharra A; Abu-Saleh N; Jeries R; Haick H; Abassi Z
Nanomedicine; 2014 Nov; 10(8):1767-76. PubMed ID: 24954383
[TBL] [Abstract][Full Text] [Related]
17. Rapid detection of sepsis in rats through volatile organic compounds in breath.
Guamán AV; Carreras A; Calvo D; Agudo I; Navajas D; Pardo A; Marco S; Farré R
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jan; 881-882():76-82. PubMed ID: 22209594
[TBL] [Abstract][Full Text] [Related]
18. In situ detection of lung cancer volatile fingerprints using bronchoscopic air-sampling.
Santonico M; Lucantoni G; Pennazza G; Capuano R; Galluccio G; Roscioni C; La Delfa G; Consoli D; Martinelli E; Paolesse R; Di Natale C; D'Amico A
Lung Cancer; 2012 Jul; 77(1):46-50. PubMed ID: 22264635
[TBL] [Abstract][Full Text] [Related]
19. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
[TBL] [Abstract][Full Text] [Related]
20. Bronchoscopically obtained volatile biomarkers in lung cancer.
Darwiche K; Baumbach JI; Sommerwerck U; Teschler H; Freitag L
Lung; 2011 Dec; 189(6):445-52. PubMed ID: 21968685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
